@beandik.cucumberpatch's testosterone therapy claims, fact-checked

What did @beandik.cucumberpatch actually say?

Almost nothing, medically speaking, and that is not a criticism. Flynn introduced himself, noted this was "day zero" of starting what he called "Sashrone" (almost certainly a phonetic rendering of a brand or formulation name, likely a compounded or prescribed testosterone product), and recorded his baseline voice, including a scream, with the stated intention of tracking vocal changes over time. That is the entirety of the medical content here.

The caption does the heavier lifting. Flynn frames this as an ongoing Q&A series for transgender and nonbinary people seeking information he wished he had access to. The implicit promise is longitudinal documentation, not a one-off claim. At 19 million views, that framing carries real weight, even when a single video says almost nothing on its own.

Does the science back this up?

The underlying premise, that testosterone causes measurable, trackable vocal changes, is well-supported. The method of baseline vocal recording is actually more scientifically sound than most people realize.

Gender-affirming testosterone therapy consistently produces voice masculinization in transmasculine individuals. A 2017 study by Azul et al. in the International Journal of Transgenderism documented significant reductions in fundamental frequency (F0), the acoustic correlate of perceived pitch, within the first months of testosterone initiation. Cosyns et al. (2014, Journal of Voice) found that F0 decreased by an average of roughly 60-70 Hz across participants, with most change occurring in the first year. Voice changes are generally considered irreversible once they occur, similar to endogenous male puberty.

Recording a "day zero" baseline is genuinely useful. Clinicians doing voice assessments before and during testosterone therapy use exactly this kind of longitudinal acoustic data. Flynn is doing informally what speech-language pathologists do formally.

What did they get wrong (or right)?

There is nothing factually wrong in what Flynn said, because he made no factual claims beyond identifying the starting point of his therapy. The screaming baseline is slightly unconventional as a voice metric, since clinical voice assessment uses standardized tasks like sustained vowel phonation or reading passages, but capturing extreme vocal range is not unreasonable for personal documentation.

One genuine concern worth naming: the product name "Sashrone" is unclear. If this refers to a compounded testosterone formulation, viewers should understand that compounded products are not FDA-approved and are not equivalent to brand-name testosterone medications in terms of regulatory oversight. That is not necessarily a reason to avoid them, many people use compounded testosterone appropriately under medical supervision, but it is a distinction that matters, and a 19-million-view platform is a reasonable place to make it explicitly.

Flynn is not wrong. He is just starting, and the series format means this video is context, not content. That is worth understanding before anyone draws conclusions from it.

What should you actually know?

If you are starting testosterone therapy and want to track your voice, here is what the research actually supports as useful baseline documentation.

• Record sustained vowel sounds ("ahh" held for 5-10 seconds) rather than screams, because screams involve falsetto-register mechanisms that are not representative of conversational voice.
• Voice changes on testosterone typically begin within 3-6 weeks and continue for 1-2 years, according to the Endocrine Society's 2017 clinical practice guidelines (Hembree et al., Journal of Clinical Endocrinology and Metabolism).
• Not everyone experiences the same degree of change. Azul et al. (2017) documented significant individual variability, and starting age, genetics, and dosing all appear to influence outcomes.
• Voice masculinization is considered a permanent change. Unlike some other testosterone effects, it does not reverse if therapy is paused or stopped.
• If voice is a significant concern, working with a speech-language pathologist who has gender-affirming care experience is an evidence-supported option, both for those who want faster adaptation and those who want to preserve more vocal range.

Flynn's series format has genuine value as lived documentation. Just make sure you are supplementing it with clinical information, not replacing one with the other.